EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
0.3619
+0.0019 (0.53%)
At close: Nov 9, 2026, 4:00 PM EST
0.3740
+0.0121 (3.34%)
Pre-market: Nov 10, 2026, 4:24 AM EST
EyePoint Revenue
EyePoint had revenue of $507.00K in the quarter ending June 30, 2026, a decrease of -90.49%. This brings the company's total for the last twelve months to $2.79M, down -94.63% year-over-year. In the year 2025, EyePoint had annual revenue of $31.37M, down -27.50%. That makes EyePoint the 41,675th largest company in the world by revenue and 5,615th in the United States.
Revenue (ttm)
$2.79M
Revenue Growth
-94.63%
P/S Ratio
11.19
Revenue / Employee
$13,028
Employees
214
Market Cap
31.20M
Revenue by Geography
- United States (U.S.) 29.98M 95.6%
- China 1.29M 4.1%
- United Kingdom (U.K.) 100.00K 0.3%
Fiscal year ended Dec 31, 2025 See the full EyePoint breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.37M | -11.90M | -27.50% |
| Dec 31, 2024 | 43.27M | -2.75M | -5.97% |
| Dec 31, 2023 | 46.02M | 4.61M | 11.14% |
| Dec 31, 2022 | 41.40M | 4.47M | 12.09% |
| Dec 31, 2021 | 36.94M | 2.50M | 7.27% |
| Dec 31, 2020 | 34.44M | 14.07M | 69.10% |
| Dec 31, 2019 | 20.37M | 17.40M | 587.77% |
| Jun 30, 2018 | 2.96M | -4.58M | -60.72% |
| Jun 30, 2017 | 7.54M | 5.92M | 365.37% |
| Jun 30, 2016 | 1.62M | -24.95M | -93.90% |
| Jun 30, 2015 | 26.57M | 23.09M | 664.90% |
| Jun 30, 2014 | 3.47M | 1.33M | 62.06% |
| Jun 30, 2013 | 2.14M | -1.38M | -39.22% |
| Jun 30, 2012 | 3.53M | -1.44M | -28.98% |
| Jun 30, 2011 | 4.97M | -18.09M | -78.46% |
| Jun 30, 2010 | 23.05M | 10.89M | 89.55% |
| Jun 30, 2009 | 12.16M | 8.69M | 249.88% |
| Jun 30, 2008 | 3.48M | 1.69M | 94.73% |
| Jun 30, 2007 | 1.79M | 749.00K | 72.30% |
| Jun 30, 2006 | 1.04M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
EYPT News
- 14 hours ago - EyePoint Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 3 days ago - EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meetings - GlobeNewsWire
- 4 days ago - EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026 - GlobeNewsWire
- 17 days ago - EyePoint downgraded to Hold from Buy at Jones - TheFly
- 20 days ago - EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals - PRNewsWire
- 20 days ago - EyePoint downgraded to Hold from Buy at Laidlaw - TheFly
- 20 days ago - EyePoint price target lowered to $1 from $5 at RBC Capital - TheFly
- 20 days ago - EyePoint downgraded to Neutral from Outperform at Mizuho - TheFly